RENOVORX, INC. (RNXT) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 1.88M USD | Liabilities, Current |
| Cash and equivalents | 9.48M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | 480.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 383.00K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.88M | $9.48M | (m) | $480.00K | $383.00K | (m) |
| 2026-03-31 | (m) | $1.92M | $12.36M | (m) | $280.00K | $379.00K | (m) |
| 2025-12-31 | (m) | $1.96M | $7.02M | (m) | $139.00K | $189.00K | (m) |
| 2025-09-30 | (m) | $1.88M | $10.04M | (m) | $169.00K | $272.00K | (m) |
| 2025-06-30 | (m) | $1.56M | $12.31M | (m) | $363.00K | (m) | (m) |
| 2025-03-31 | (m) | $1.74M | $14.58M | (m) | $242.00K | (m) | (m) |
| 2024-12-31 | (m) | $1.91M | $7.15M | (m) | $43.00K | (m) | (m) |
| 2024-09-30 | (m) | $1.77M | $9.56M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $1.31M | $11.74M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $1.09M | $4.39M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $1.18M | $1.17M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $1.60M | $3.23M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $1.70M | $5.95M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | $3.72M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $4.39M | $2.05M | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | $3.09M | $5.02M | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | $2.77M | $8.00M | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | $13.12M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $938.00K | $15.19M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $625.00K | $17.73M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $4.10M | $1.79M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |